According to a market report by Lucintel, the future of the global malaria vaccine market looks promising with opportunities in the hospital, specialty clinic, and homecare markets. The global malaria vaccine market is expected to reach an estimated $6.9 billion by 2030 with a CAGR of 18.6% from 2024 to 2030.
The major drivers for this market are growing demand for malaria
vaccines, emergence of pre-erythrocytic vaccines, and rising preference for
vaccine delivery platforms.
In this market, pre-erythrocytic, erythrocytic, and multi-antigen are the
major segments of malaria vaccine market by type.
Lucintel forecasts that pre-erythrocytic is expected to witness highest
growth over the forecast period.
Within this market, hospital is expected to witness highest growth over
the forecast period.
North America will remain the largest region due to existence of robust
healthcare infrastructure, high investment in vaccines research and
development, and presence of key manufacturers in the region.
Actiza Pharmaceutical, AdvaCare Pharma, Ipca Laboratories, Bliss GVS
Pharma, GeoVax, Sumaya Biotech, VLP Therapeutics, OSIVAX, AJANTA PHARMA, and
Strides Pharma Science are the major suppliers in the malaria vaccine market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract
Manufacturing Market
3. Stent Market
5. 3D Printing Medical
Device Market
8. Medical Lifting Sling Market
10. Stretcher Market
No comments:
Post a Comment